An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

VanBlargan, LA; Errico, JM; Halfmann, PJ; Zost, SJ; Crowe, JE; Purcell, LA; Kawaoka, Y; Corti, D; Fremont, DH; Diamond, MS

Diamond, MS (通讯作者),Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.;Diamond, MS (通讯作者),Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.;Diamond, MS (通讯作者),Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.;Diamond, MS (通讯作者),Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63110 USA.;Diamond, MS (通讯作者),Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.;Diamond, MS (通讯作者),Washington Univ

NATURE MEDICINE, 2022; 28 (3): 490

Abstract

The emergence of the highly transmissible B.1.1.529 Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for ......

Full Text Link